Promising Off-the-Shelf Cancer Vaccine Extends Survival and Prevents Recurrence
An experimental off-the-shelf cancer vaccine called ELI-002 shows promising early results in prolonging survival and inducing immune responses in patients with pancreatic and colorectal cancers harboring KRAS mutations, with further trials underway to confirm its efficacy.